AMG Reports Financial and Operating Results for the First Quarter of 2017
May 01, 2017 11:35 am UTC| Business
Company Reports EPS of $2.13; Economic EPS of $3.21 WEST PALM BEACH, Fla., May 01, 2017 -- Affiliated Managers Group, Inc. (NYSE:AMG) today reported its financial and operating results for the quarter ended March 31,...
Animal Biotechnology Technologies, Markets and Companies 2016-2026
May 01, 2017 11:31 am UTC| Business
Dublin, May 01, 2017 -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "Animal Biotechnology - Technologies, Markets and Companies" to their offering. ...
BroadSoft Reports First Quarter 2017 Financial Results
May 01, 2017 11:31 am UTC| Business
GAITHERSBURG, Md., May 01, 2017 -- BroadSoft, Inc. (NASDAQ:BSFT), the leading global provider of software and services that enable telecommunications service providers to deliver hosted, cloud-based Unified...
BroadSoft Reports First Quarter 2017 Financial Results
May 01, 2017 11:31 am UTC| Business
GAITHERSBURG, Md., May 01, 2017 -- BroadSoft, Inc. (NASDAQ:BSFT), the leading global provider of software and services that enable telecommunications service providers to deliver hosted, cloud-based Unified...
Forward Pharma Further Aligns Cost Structure with Focus Following Settlement and License Agreement
May 01, 2017 11:30 am UTC| Business
COPENHAGEN, Denmark, May 01, 2017 -- Forward Pharma A/S (NASDAQ:FWP) (“we” or “Forward” or the “Company”) today provided an update on the Company’s strategic focus and related initiatives to reduce operating and...
May 01, 2017 11:30 am UTC| Business
SOUTH SAN FRANCISCO, Calif., May 01, 2017 -- Cytokinetics, Inc. (Nasdaq:CYTK) today announced that results from the dose escalation phase of COSMIC-HF (Chronic Oral Study of Myosin Activation to Increase Contractility...
Intra-Cellular Therapies Provides Corporate Update On Schizophrenia Program
May 01, 2017 11:30 am UTC| Business
NEW YORK, May 01, 2017 -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today provided a corporate...